International incidence and mortality trends of liver cancer: a global profile

We examined the global incidence and mortality rates of liver cancer, and evaluated the association between incidence/mortality and socioeconomic development (Human Development Index [HDI] and Gross Domestic Product [GDP]) using linear regression analysis. The average annual percent change (AAPC) of the trends was evaluated from join-point regression analysis. The global incidence of liver cancer varied widely by nine-fold, and was negatively correlated with HDI (men: r = −0.232, p = 0.003; women: r = −0.369, p < 0.001) and GDP per capita (men: r = −0.164, p = 0.036; women: r = −0.212, p = 0.007). Its mortality showed a similarly negative correlation with both indices. The greatest incidence rise in men was observed in Poland (AAPC = 17.5, 95% C.I. = 5.6, 30.9) and Brazil (AAPC = 13.2, 95% C.I. = 5.9, 21.0), whereas Germany (AAPC = 6.6, 95% C.I = 2.0, 11.5) and Norway (AAPC = 6.5, 95% C.I. = 3.2, 10.0) had the greatest increase in women. The mortality rates paralleled the incidence rates in most countries. For mortality, Malta (AAPC = 11.5, 95% C.I. = 3.9, 19.8), Australia (AAPC = 6.8, 95% C.I. = 2.2, 11.5) and Norway (APCC = 5.6, 95% C.I. = 2.8, 8.5) reported the biggest increase among men; whilst Australia (AAPC = 13.4, 95% C.I. = 7.8, 19.4) and Singapore (AAPC = 7.7, 95% C.I. = 4.1, 11.5) showed the most prominent rise among women. These epidemiological data identified countries with potentially increasing trends of liver cancer for preventive actions.

[1]  M. Kurihara,et al.  Geographical observation on cancer mortality by selected sites on the basis of standardised death rate. , 1957, Gan.

[2]  M. Stepanova,et al.  Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  T. Seeman,et al.  Socioeconomic and ethnic disparities in cardiovascular risk in the United States, 2001-2006. , 2010, Annals of epidemiology.

[4]  Carlo La Vecchia,et al.  Hepatocellular carcinoma epidemiology. , 2014, Best practice & research. Clinical gastroenterology.

[5]  Ahmedin Jemal,et al.  International Trends in Liver Cancer Incidence Rates , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[6]  B. Bell,et al.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.

[7]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.

[8]  Alan D. Lopez,et al.  Counting the dead and what they died from: an assessment of the global status of cause of death data. , 2005, Bulletin of the World Health Organization.

[9]  W. Blonski,et al.  Non-viral causes of hepatocellular carcinoma. , 2010, World journal of gastroenterology.

[10]  R. Murray,et al.  A structural equation model of the effect of poverty and unemployment on alcohol abuse. , 2002, Addictive behaviors.

[11]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[12]  R. Tiwari,et al.  (www.interscience.wiley.com) DOI: 10.1002/sim.3733 Estimating average annual per cent change in trend analysis , 2022 .

[13]  D. Hodgson.  Review of Human Development Report 2013: The Rise of the South: Human Progress in a Diverse World, by UNDP. , 2013 .

[14]  L. Morales,et al.  Risk Factors for Chronic Liver Disease in Blacks, Mexican Americans, and Whites in the United States: Results From NHANES IV, 1999–2004 , 2008, The American Journal of Gastroenterology.

[15]  K. McGlynn,et al.  Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. , 2015, Clinics in liver disease.

[16]  Hideo Tanaka,et al.  Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures , 2011, Journal of epidemiology.

[17]  Ichiro Kawachi,et al.  Socioeconomic disparities in metabolic syndrome differ by gender: evidence from NHANES III. , 2007, Annals of epidemiology.

[18]  J. Fraumeni,et al.  International trends and patterns of primary liver cancer , 2001, International journal of cancer.

[19]  Sahil Mittal,et al.  Epidemiology of hepatocellular carcinoma: consider the population. , 2013, Journal of clinical gastroenterology.

[20]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[21]  C. Pairojkul,et al.  Roles of liver fluke infection as risk factor for cholangiocarcinoma , 2014, Journal of hepato-biliary-pancreatic sciences.

[22]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[23]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[24]  F. Bray,et al.  International Patterns of Cancer Incidence and Mortality , 2009 .

[25]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[26]  S. Promthet,et al.  Development of a community-based approach to opisthorchiasis control. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[27]  K. Malik,et al.  Human Development Report 2013. The Rise of the South: Human Progress in a Diverse World , 2013 .

[28]  D. Trichopoulos,et al.  Infection with hepatitis B and C viruses, social class and cancer. , 1997, IARC scientific publications.

[29]  H. Ahmad,et al.  Effects of socioeconomic factors on obesity rates in four southern states and Colorado. , 2011, Ethnicity & disease.

[30]  Martin CS Wonga,et al.  Global incidence and mortality of prostate cancer: analysis of temporal , 2017 .

[31]  C. Mathers,et al.  Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions , 2012, The Lancet.

[32]  D. Roblin,et al.  HCV screening practices and prevalence in an MCO, 2000-2007. , 2011, The American journal of managed care.

[33]  P. Klenerman,et al.  Hepatitis C , 2015, The Lancet.

[34]  Ahmedin Jemal,et al.  Global Cancer Incidence and Mortality Rates and Trends—An Update , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[35]  Edoardo Cervoni,et al.  Hepatitis C , 1998, The Lancet.

[36]  H. Tsukuma,et al.  Declining Incidence of Hepatocellular Carcinoma in Osaka, Japan, from 1990 to 2003 , 2008, Annals of Internal Medicine.

[37]  K. McGlynn,et al.  Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. , 2004, Gastroenterology.

[38]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[39]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.